🔎 Trials Near Me

Gara Jalqabaatti › Dermatitis Atopic (Eczema) › Pennsylvania › Philadelphia

Qorannoo klinikaalii Dermatitis Atopic (Eczema) Philadelphia, PA keessatti

Qorannoo 6 Dermatitis Atopic (Eczema) f Philadelphia fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Namoota walitti qabaa jiraSadarkaa 2
  • Paddington Testing Co, Inc, Philadelphia
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07216027

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
  • Paddington Testing Company, Philadelphia
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06564389

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Namoota walitti qabaa jiraSadarkaa 3
  • Clinical Research of Philadelphia /ID# 264972, Philadelphia
  • Dermatology Associates of Plymouth Meeting /ID# 267286, Plymouth Meeting · Miili 12 fagaatti
Umuriin 18 hanga 63 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06389136

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 2
  • Paddington Testing Co, Inc, Philadelphia
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Cam-2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Galderma Investigational Site 8559, Philadelphia
  • Galderma Investigational Site 7103, Philadelphia
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT06988605

A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

Namoota walitti qabaa jiraSadarkaa 1
  • University of Pennsylvania, Philadelphia
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Ful-2025 · NCT06055361

Qorannoo Dermatitis Atopic (Eczema) magaalota biroo keessatti

Qorannoo biroo Philadelphia keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.